ABC Arbitrage’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

ABC Arbitrage’s Portfolio ITCI Stock Details ITCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-40,679	Closed	-$5.37M	–	283
2025 Q1	$5.37M	Buy	+40,679	New	+$5.07M	1%	22

Other funds holding ITCI

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

KIM

Kestra Investment Management Austin, Texas $5.8B AUM 14.71% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

ABC Arbitrage's ITCI Position: Q2 2025 in Review

ABC Arbitrage sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 40,679 shares — an estimated $5.37M sold.

ABC Arbitrage first reported a position in ITCI in Q1 2025 and held it in 1 quarter. The position peaked at $5.37M in Q1 2025. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

ABC Arbitrage reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
ABC Arbitrage sold 40,679 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $5.37M.
ABC Arbitrage first reported a position in Intra-Cellular Therapies Inc. in Q1 2025 and held it in 1 quarter.
ABC Arbitrage's Intra-Cellular Therapies Inc. position peaked at $5.37M in Q1 2025.
4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on ABC Arbitrage's 13F filing for Q2 2025, filed 8 Aug 2025.